Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 236

1.

Long-term vigabatrin treatment modifies pentylenetetrazole-induced seizures in mice: focused on GABA brain concentration.

Świąder MJ, Świąder K, Zakrocka I, Krzyżanowski M, Wróbel A, Łuszczki JJ, Czuczwar SJ.

Pharmacol Rep. 2019 Dec 20. doi: 10.1007/s43440-019-00037-6. [Epub ahead of print]

PMID:
32048251
2.

Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia.

Ułamek-Kozioł M, Czuczwar SJ, Januszewski S, Pluta R.

Int J Mol Sci. 2020 Jan 14;21(2). pii: E517. doi: 10.3390/ijms21020517. Review.

3.

Common Proteomic and Genomic Contribution to Ischemic Brain Damage and Alzheimer’s Disease.

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

In: Wisniewski T, editor. Alzheimer’s Disease [Internet]. Brisbane (AU): Codon Publications; 2019 Dec 20. Chapter 4.

4.

Expression of the Tau Protein and Amyloid Protein Precursor Processing Genes in the CA3 Area of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.

Pluta R, Ułamek-Kozioł M, Kocki J, Bogucki J, Januszewski S, Bogucka-Kocka A, Czuczwar SJ.

Mol Neurobiol. 2020 Feb;57(2):1281-1290. doi: 10.1007/s12035-019-01799-z. Epub 2019 Nov 12.

PMID:
31713815
5.

Dysregulation of Autophagy, Mitophagy, and Apoptosis Genes in the CA3 Region of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.

Ułamek-Kozioł M, Czuczwar SJ, Kocki J, Januszewski S, Bogucki J, Bogucka-Kocka A, Pluta R.

J Alzheimers Dis. 2019;72(4):1279-1286. doi: 10.3233/JAD-190966.

6.

Ketogenic Diet and Epilepsy.

Ułamek-Kozioł M, Czuczwar SJ, Januszewski S, Pluta R.

Nutrients. 2019 Oct 18;11(10). pii: E2510. doi: 10.3390/nu11102510. Review.

7.

Ketogenic Diet in Alzheimer's Disease.

Rusek M, Pluta R, Ułamek-Kozioł M, Czuczwar SJ.

Int J Mol Sci. 2019 Aug 9;20(16). pii: E3892. doi: 10.3390/ijms20163892. Review.

8.

An update on the problem of osteoporosis in people with epilepsy taking antiepileptic drugs.

Miziak B, Chrościńska-Krawczyk M, Czuczwar SJ.

Expert Opin Drug Saf. 2019 Aug;18(8):679-689. doi: 10.1080/14740338.2019.1625887. Epub 2019 Jun 6. Review.

PMID:
31159612
9.

Can pharmacotherapy play a role in treating internet addiction disorder?

Łukawski K, Rusek M, Czuczwar SJ.

Expert Opin Pharmacother. 2019 Aug;20(11):1299-1301. doi: 10.1080/14656566.2019.1612366. Epub 2019 May 6. No abstract available.

PMID:
31058549
10.

Influence of salbutamol on the anticonvulsant potency of the antiepileptic drugs in the maximal electroshock-induced seizures in mice.

Świąder M, Zakrocka I, Świąder K, Zawadzki A, Łuszczki JJ, Czuczwar SJ, Munir D.

Pharmacol Rep. 2019 Jun;71(3):466-472. doi: 10.1016/j.pharep.2019.02.003. Epub 2019 Feb 8.

PMID:
31003159
11.

Drug-drug interactions between antiepileptics and cannabinoids.

Miziak B, Walczak A, Szponar J, Pluta R, Czuczwar SJ.

Expert Opin Drug Metab Toxicol. 2019 May;15(5):407-415. doi: 10.1080/17425255.2019.1605355. Epub 2019 Apr 16. Review.

PMID:
30991855
12.

Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype.

Pluta R, Ułamek-Kozioł M, Czuczwar SJ.

Int J Mol Sci. 2018 Dec 12;19(12). pii: E4002. doi: 10.3390/ijms19124002. Review.

13.

Advances with extended and controlled release formulations of antiepileptics in the elderly.

Banach M, Miziak B, Borowicz-Reutt KK, Czuczwar SJ.

Expert Opin Pharmacother. 2019 Feb;20(3):333-341. doi: 10.1080/14656566.2018.1549543. Epub 2018 Nov 27. Review.

PMID:
30482057
14.

Effect of aliskiren, a direct renin inhibitor, on the protective action of antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice.

Łukawski K, Raszewski G, Czuczwar SJ.

Fundam Clin Pharmacol. 2019 Apr;33(2):191-198. doi: 10.1111/fcp.12421. Epub 2018 Nov 21.

PMID:
30312501
15.

Tau Protein Dysfunction after Brain Ischemia.

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

J Alzheimers Dis. 2018;66(2):429-437. doi: 10.3233/JAD-180772. Review.

16.

Ischemic tau protein gene induction as an additional key factor driving development of Alzheimer's phenotype changes in CA1 area of hippocampus in an ischemic model of Alzheimer's disease.

Pluta R, Bogucka-Kocka A, Ułamek-Kozioł M, Bogucki J, Januszewski S, Kocki J, Czuczwar SJ.

Pharmacol Rep. 2018 Sep;70(5):881-884. doi: 10.1016/j.pharep.2018.03.004. Epub 2018 Mar 16.

PMID:
32002968
17.

Ischemic tau protein gene induction as an additional key factor driving development of Alzheimer's phenotype changes in CA1 area of hippocampus in an ischemic model of Alzheimer's disease.

Pluta R, Bogucka-Kocka A, Ułamek-Kozioł M, Bogucki J, Januszewski S, Kocki J, Czuczwar SJ.

Pharmacol Rep. 2018 Oct;70(5):881-884. doi: 10.1016/j.pharep.2018.03.004. Epub 2018 Mar 16.

PMID:
30096486
18.

A viewpoint on rational and irrational fixed-drug combinations.

Błaszczyk B, Miziak B, Czuczwar P, Wierzchowska-Cioch E, Pluta R, Czuczwar SJ.

Expert Rev Clin Pharmacol. 2018 Aug;11(8):761-771. doi: 10.1080/17512433.2018.1500895. Epub 2018 Jul 23. Review.

PMID:
30024271
19.

Platelets, lymphocytes and erythrocytes from Alzheimer's disease patients: the quest for blood cell-based biomarkers.

Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ.

Folia Neuropathol. 2018;56(1):14-20. doi: 10.5114/fn.2018.74655. Review.

20.

Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies.

Łukawski K, Andres-Mach M, Czuczwar M, Łuszczki JJ, Kruszyński K, Czuczwar SJ.

Pharmacol Rep. 2018 Apr;70(2):284-293. doi: 10.1016/j.pharep.2017.07.012. Epub 2017 Jul 16. Review.

PMID:
29477036

Supplemental Content

Loading ...
Support Center